Alopecia Areata Clinical Trials

Find Alopecia Areata Clinical Trials Near You

Evaluation of UV-Trichoscopic Red Fluorescence Intensity in Relation to Trichoscopic Findings and Response to Intralesional Corticosteroid Treatment in Limited Plaque-Type Alopecia Areata

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

The goal of this observational study is to learn whether red fluorescence seen with ultraviolet (UV) trichoscopy is related to disease findings and treatment response in adults with limited plaque-type alopecia areata. Trichoscopy is a close-up imaging method used to examine the hair and scalp. The study will investigate whether the amount of red fluorescence at the beginning of the study is related to how soon hair starts to grow back, how much hair regrows, and how trichoscopic findings change during follow-up. Participants for whom intralesional corticosteroid treatment has been planned as part of their regular medical care will have standard trichoscopic and UV-trichoscopic images taken of the affected scalp area. They will be followed at weeks 4, 8, and 12, when hair regrowth and changes in scalp and hair findings will be evaluated. Researchers will measure red fluorescence in the images and examine whether it is related to treatment response over time.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age 18 years or older

• Limited plaque-type alopecia areata of the scalp

• Active hair loss

• Symptom onset within the previous 6 months

• No topical, intramuscular, or oral treatment for alopecia areata within the previous 1 month

• No intralesional corticosteroid treatment within the previous 6 weeks

• Provision of informed consent

Locations
Other Locations
Turkey
Istanbul Training and Research Hospital
RECRUITING
Istanbul
Contact Information
Primary
Sevgi Nazli Apucu, Dermatology Resident Physician
snapucu@gmail.com
+905374048180
Time Frame
Start Date: 2026-07-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 40
Treatments
Limited Plaque-Type Alopecia Areata
Adults with limited plaque-type alopecia areata who are receiving intralesional corticosteroid treatment as part of routine clinical care. Participants will undergo conventional trichoscopic and UV-trichoscopic assessments at baseline and during follow-up at weeks 4, 8, and 12. Hair regrowth, trichoscopic findings, and UV-trichoscopic red fluorescence intensity will be evaluated over time.
Sponsors
Leads: Istanbul Training and Research Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials